B-TYPE NATRIURETIC PEPTIDE PROTEOLYTIC ASSAY FOR CARDIOVASCULAR DISEASE RISK ASSESSMENT

摘要

Described herein are methods for assessing the risk of cardiovascular disease in a subject in need thereof by detecting the presence of one or more cleavage products of the one or more natriuretic peptides over a period of time, wherein the presence of one or more cleavage products is indicative of an increased risk of the subject developing cardiovascular disease.